vs
Side-by-side financial comparison of Dexcom (DXCM) and iQIYI, Inc. (IQ). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $971.6M, roughly 1.3× iQIYI, Inc.).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
iQIYI, Inc.IQEarnings & Financial Report
iQIYI, formerly Qiyi, is a Chinese subscription video on-demand over-the-top streaming service owned by Baidu. Headquartered in Beijing, iQIYI primarily produces and distributes films and television series.
DXCM vs IQ — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $971.6M |
| Net Profit | $267.3M | — |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 0.8% |
| Net Margin | 21.2% | — |
| Revenue YoY | 21.6% | — |
| Net Profit YoY | 153.6% | — |
| EPS (diluted) | $0.67 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $971.6M | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.0B | $906.0M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $994.2M | — | ||
| Q2 24 | $1.0B | — |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | — | ||
| Q2 25 | $179.8M | — | ||
| Q1 25 | $105.4M | — | ||
| Q4 24 | $151.7M | — | ||
| Q3 24 | $134.6M | — | ||
| Q2 24 | $143.5M | — |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | 0.8% | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 12.9% | 4.3% | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 15.7% | — |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | — | ||
| Q2 25 | 15.5% | — | ||
| Q1 25 | 10.2% | — | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 14.3% | — |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | — | ||
| Q3 25 | $0.70 | — | ||
| Q2 25 | $0.45 | — | ||
| Q1 25 | $0.27 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.34 | — | ||
| Q2 24 | $0.35 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $4.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $13.3M |
| Total Assets | $6.3B | $46.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | $4.4M | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | $3.5M | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | $2.7B | $13.3M | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.7B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.3B | $13.4M | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.4B | — |
| Q1 26 | $6.3B | $46.7M | ||
| Q4 25 | $6.3B | — | ||
| Q3 25 | $7.5B | — | ||
| Q2 25 | $7.3B | — | ||
| Q1 25 | $6.8B | $45.8M | ||
| Q4 24 | $6.5B | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.8B | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
